PureHealth Achieves Remarkable USD 550 Million Net Profit, Announces Dividend for 2025
In a significant financial milestone, PureHealth Holding PJSC, the largest healthcare group in the Middle East, has reported impressive financial results for the fiscal year 2025. The company, recognized by the ADX during trading as PUREHEALTH, generated a net profit of USD 550 million, reflecting a 17.7% increase compared to the previous year. This performance highlights the resilience and strength of PureHealth's operations as it continues to expand its services across global markets.
The group's revenue for FY 2025 totaled USD 7.4 billion, a 5.7% increase motivated by robust demand and enhanced performance across its core segments: Healthcare (Care) and Insurance (Cover). The significant progress in these verticals contributed to an impressive EBITDA of USD 1.3 billion, marking a 16.1% year-on-year growth driven primarily by operational efficiencies.
Highlighting its commitment to shareholder value, PureHealth has proposed a cash dividend of USD 163 million for FY 2025, which constitutes about 30% of the net profit. This move, pending regulatory and shareholder approvals, signals PureHealth’s solid cash generation capacity and the strategic allocation of capital, ensuring ongoing support for its expansion initiatives without compromising future growth prospects.
Chairman H.E. Kamal Al Maazmi emphasized that 2025 marked a pivotal year for the company, as it moves toward becoming a technology-enabled global healthcare organization. With a focus on international markets, including the USA, UK, Greece, and Cyprus, PureHealth aims to solidify its operations and clinical capabilities, proving that a balanced approach to local and international growth is achievable and sustainable.
The year was characterized by key acquisitions, notably the EUR 800 million purchase of a 60% stake in Hellenic Healthcare Group, which operates multiple hospitals and diagnostic centers in Greece and Cyprus. This strategic move reflects PureHealth’s ambition to expand its portfolio and enhance service offerings in competitive markets.
Despite challenges posed by fluctuating market conditions globally, PureHealth's innovative approaches to healthcare delivery, including investments in AI and digital health solutions, are strategically positioning the group ahead in the new era of healthcare services. The establishment of the largest AI-powered standalone diagnostic laboratory in the UAE underlines its commitment to leveraging technology for enhanced patient outcomes.
Operational enhancements were also seen throughout its UAE network, which expanded its operational footprint by increasing inpatient and outpatient capacities and introducing specialty clinics. The impressive growth statistics indicate a 14% increase in inpatient volumes, supported by corresponding growth in laboratory and surgical metrics, further solidifying PureHealth’s status in the regional healthcare landscape.
In addition to enhancing Care services, PureHealth also improved its Cover vertical by achieving a 13.5% increase in revenue, driven by a 9% increase in gross written premiums and solid customer enrollment trends, thereby increasing its membership base to 3.4 million patients within the period.
PureHealth recognizes that the healthcare market requires resilience against ever-evolving demands, which is why the group's strategic direction includes a focus on innovation and technological integration, aiming for optimum results through AI-enabled healthcare solutions. By capitalizing on synergies from recent acquisitions and implementing cutting-edge technologies, PureHealth is setting robust foundations for future growth.
Furthermore, the group is initiating sector expansions in specialized healthcare lines, thus ensuring the delivery of superior care, especially in underrepresented areas. The introduction of comprehensive services centered around longevity and precision medicine, along with nationwide mental health services, showcases PureHealth's proactive approach to emerging healthcare trends.
Looking ahead, PureHealth remains optimistic, with a commitment to investing in both local and international growth, ensuring its revenues are equally represented in varied markets. With a vision to generate 50% of its revenue from international markets, PureHealth is focused on optimizing its operational capacities while driving shareholder returns through strategic investments and expanding its healthcare offerings across multiple regions. This strategic foresight ensures that PureHealth will remain a formidable player in the global healthcare market well into the future.
The group's revenue for FY 2025 totaled USD 7.4 billion, a 5.7% increase motivated by robust demand and enhanced performance across its core segments: Healthcare (Care) and Insurance (Cover). The significant progress in these verticals contributed to an impressive EBITDA of USD 1.3 billion, marking a 16.1% year-on-year growth driven primarily by operational efficiencies.
Highlighting its commitment to shareholder value, PureHealth has proposed a cash dividend of USD 163 million for FY 2025, which constitutes about 30% of the net profit. This move, pending regulatory and shareholder approvals, signals PureHealth’s solid cash generation capacity and the strategic allocation of capital, ensuring ongoing support for its expansion initiatives without compromising future growth prospects.
Chairman H.E. Kamal Al Maazmi emphasized that 2025 marked a pivotal year for the company, as it moves toward becoming a technology-enabled global healthcare organization. With a focus on international markets, including the USA, UK, Greece, and Cyprus, PureHealth aims to solidify its operations and clinical capabilities, proving that a balanced approach to local and international growth is achievable and sustainable.
The year was characterized by key acquisitions, notably the EUR 800 million purchase of a 60% stake in Hellenic Healthcare Group, which operates multiple hospitals and diagnostic centers in Greece and Cyprus. This strategic move reflects PureHealth’s ambition to expand its portfolio and enhance service offerings in competitive markets.
Despite challenges posed by fluctuating market conditions globally, PureHealth's innovative approaches to healthcare delivery, including investments in AI and digital health solutions, are strategically positioning the group ahead in the new era of healthcare services. The establishment of the largest AI-powered standalone diagnostic laboratory in the UAE underlines its commitment to leveraging technology for enhanced patient outcomes.
Operational enhancements were also seen throughout its UAE network, which expanded its operational footprint by increasing inpatient and outpatient capacities and introducing specialty clinics. The impressive growth statistics indicate a 14% increase in inpatient volumes, supported by corresponding growth in laboratory and surgical metrics, further solidifying PureHealth’s status in the regional healthcare landscape.
In addition to enhancing Care services, PureHealth also improved its Cover vertical by achieving a 13.5% increase in revenue, driven by a 9% increase in gross written premiums and solid customer enrollment trends, thereby increasing its membership base to 3.4 million patients within the period.
PureHealth recognizes that the healthcare market requires resilience against ever-evolving demands, which is why the group's strategic direction includes a focus on innovation and technological integration, aiming for optimum results through AI-enabled healthcare solutions. By capitalizing on synergies from recent acquisitions and implementing cutting-edge technologies, PureHealth is setting robust foundations for future growth.
Furthermore, the group is initiating sector expansions in specialized healthcare lines, thus ensuring the delivery of superior care, especially in underrepresented areas. The introduction of comprehensive services centered around longevity and precision medicine, along with nationwide mental health services, showcases PureHealth's proactive approach to emerging healthcare trends.
Looking ahead, PureHealth remains optimistic, with a commitment to investing in both local and international growth, ensuring its revenues are equally represented in varied markets. With a vision to generate 50% of its revenue from international markets, PureHealth is focused on optimizing its operational capacities while driving shareholder returns through strategic investments and expanding its healthcare offerings across multiple regions. This strategic foresight ensures that PureHealth will remain a formidable player in the global healthcare market well into the future.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.